2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo | Journal of Experimental & Clinical Cancer Research | Full Text

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo | Journal of Experimental & Clinical Cancer Research | Full Text

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo

Fermented wheat germ extract has been reported to exert various pharmacological activities, including anti-oxidant, anti-cell growth and cell apoptosis in various cancer cells. Although 2,6-dimethoxy-1,4-benzo...

Authors:Xueyin Zu, Xiaoli Ma, Xiaomeng Xie, Bingbing Lu, Kyle Laster, Kangdong Liu, Zigang Dong and Dong Joon Kim

Citation:Journal of Experimental & Clinical Cancer Research 2020 39:107

Content type:Research

 

Published on: 9 June 2020

• ViewFull Text
 
• ViewPDF